Paul W. Hoelscher

2018

In 2018, Paul W. Hoelscher earned a total compensation of $7M as Executive Vice President, Chief Financial Officer at Horizon Pharma, a 656% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$553,809
Salary$563,750
Stock Awards$5,812,495
Other$104,332
Total$7,034,386

Hoelscher received $5.8M in stock awards, accounting for 83% of the total pay in 2018.

Hoelscher also received $553.8K in non-equity incentive plan, $563.8K in salary and $104.3K in other compensation.

Rankings

In 2018, Paul W. Hoelscher's compensation ranked 1,229th out of 14,244 executives tracked by ExecPay. In other words, Hoelscher earned more than 91.4% of executives.

ClassificationRankingPercentile
All
1,229
out of 14,244
91st
Division
Manufacturing
422
out of 5,765
93rd
Major group
Chemicals And Allied Products
131
out of 2,128
94th
Industry group
Drugs
102
out of 1,817
94th
Industry
Pharmaceutical Preparations
73
out of 1,391
95th

Pay ratio

Paul W. Hoelscher's Pay$7,034,386
Median Employee's Pay$207,196
Pay Ratio

34

to 1

In 2018, the annual total compensation of Paul W. Hoelscher was $7,034,386.

The annual total compensation of the median employee at Horizon Pharma was $207,196.

The ratio of Paul W. Hoelscher's pay to the pay of median employee was therefore 34 to one.

Source: SEC filing on April 8, 2019.

Hoelscher's colleagues

We found six more compensation records of executives who worked with Paul W. Hoelscher at Horizon Pharma in 2018.

2018

Timothy Walbert

Horizon Pharma

Chief Executive Officer

2018

Robert Carey

Horizon Pharma

Executive Vice President, Chief Business Officer

2018

Shao-Lee Lin

Horizon Pharma

Chief Scientific Officer

2018

Jeffrey FACP

Horizon Pharma

Chief Medical Officer

2018

Barry Moze

Horizon Pharma

Chief Administrative Officer

2018

Vikram Karnani

Horizon Pharma

Executive Vice President, Chief Commercial Officer

News

You may also like